Clinical Trials
29 trialsDCE-MRI
University Hospital, Ghent
Nab-PIPAC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
SUROVA
Clinica Universidad de Navarra, Universidad de Navarra
Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis
University of Kansas Medical Center
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer
Shanghai Yunying Medical Technology
Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis
Instituto do Cancer do Estado de São Paulo
The Role of Pre-operative and Post-operative Circulating Tumor Cells in Gastric Cancer.
Chang Gung Memorial Hospital
Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases
Sun Yat-sen University
Role of Magnetic Resonance Enterography for Predicting Peritoneal Cancer Index
Chang Gung Memorial Hospital
A Phase II Study of Conversion Surgery After IP Paclitaxel With XELOX Chemotherapy in AGC With Peritoneal Dissemination
Gangnam Severance Hospital
Preoperative Abdominal Enhanced CT, 18F-FDG PET/CT and 68Ga-FAPI PET/CT in Peritoneal Carcinomatosis of Gastric Cancer
Fujian Medical University
OPAC
University Hospital, Geneva
Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial
Sheba Medical Center
Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Intraoperative ICG Fluorescence Imaging for Peritoneal Carcinomatosis Detection
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
DISCO
The Netherlands Cancer Institute
PIPACRegis
University of Magdeburg
PIPAC_01
University of Leipzig
MMIPC
Radboud University Medical Center
EDMONd
Royal Surrey County Hospital NHS Foundation Trust
Peritoneal Carcinomatosis Extent Evaluation: Radiologic, Laparoscopic and Pathologic.
South Egypt Cancer Institute
hipecova
Hospital General de Ciudad Real
Prospective Intraperitoneal Chemotherapy in Carcinomatosis Cohort Study
Kantonsspital Winterthur KSW
Hypericin-PDT
University Hospital Tuebingen
Clinical Analysis of HIPEC for T4 Colorectal Cancer After Surgery
Sixth Affiliated Hospital, Sun Yat-sen University
Efficacy of HIPEC Combined With Systemic Chemotherapy and CRS on Peritoneal Metastases From Gastric Cancer
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Pathophysiology of Inflammation After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
University of Zurich
DNA Single Nucleotide Polymorphisms as Predictors of Toxicity
OvaGene Oncology, Inc.
IPHC
Wuhan University